TMO Thermo Fisher Scientific Inc

  1. Stocks
  2. Healthcare
  3. NYSE: TMO

Price (delayed)

$703.435

Market cap

$260.63B

P/E Ratio

37.04

Dividend/share

$1.84

EPS

$18.99

Enterprise value

$296.54B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 67

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner ...

Highlights
Thermo Fisher Scientific's quick ratio has increased by 32% YoY and by 23% from the previous quarter
TMO's EPS is up by 10% year-on-year
The debt has increased by 16% YoY but it has decreased by 2.8% QoQ
The stock's price to earnings (P/E) is 24% more than its last 4 quarters average of 30.4 and 19% more than its 5-year quarterly average of 31.8
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.thermofisher.com
Peers: BDX WAT BIO ISRG

Key stats

What are the main financial stats of TMO

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
-1.99%
1 week
3.91%
1 month
6.22%
1 year
19.63%
YTD
21.4%
QTD
4.2%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$47.35B
Gross profit
$19.45B
Operating income
$8.47B
Net income
$7.07B
Gross margin
41.1%
Net margin
14.9%
The operating income has grown by 13% YoY and by 4% from the previous quarter
Thermo Fisher Scientific's net income has increased by 8% YoY
Thermo Fisher Scientific's revenue has increased by 8% YoY and by 2.2% from the previous quarter
Thermo Fisher Scientific's gross profit has increased by 8% YoY and by 2.9% from the previous quarter

Price vs fundamentals

How does TMO's price correlate with its fundamentals

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
TMO P/E details
P/E
37.04
P/B
4.75
P/S
5.5
EV/EBIT
31.71
EV/EBITDA
23.81
EV/Sales
6.26
The stock's price to earnings (P/E) is 24% more than its last 4 quarters average of 30.4 and 19% more than its 5-year quarterly average of 31.8
TMO's EPS is up by 10% year-on-year
The P/B is 24% above the last 4 quarters average of 3.9 and 8% above the 5-year quarterly average of 4.5
The company's equity rose by 7% YoY and by 4% QoQ
The P/S is 25% above the last 4 quarters average of 4.5 and 17% above the 5-year quarterly average of 4.8
Thermo Fisher Scientific's revenue has increased by 8% YoY and by 2.2% from the previous quarter

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's ROA is down by 4.5% YoY
TMO's return on invested capital is down by 4.5% year-on-year

Dividends

What is TMO's dividend history
Dividend details
DPS
$1.84
Dividend yield
0.26%
Payout ratio
9.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 92% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has increased by 32% YoY and by 23% from the previous quarter
The current ratio has increased by 21% year-on-year and by 17% since the previous quarter
The debt is 24% lower than the equity
The debt has increased by 16% YoY but it has decreased by 2.8% QoQ
Thermo Fisher Scientific's debt to equity has increased by 9% YoY but it has decreased by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.